- Home
- CMMB vs BNZI Comparison
CMMB vs BNZI Comparison
Compare CMMB & BNZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CMMB | BNZI |
|---|---|---|
| Founded | 2004 | 2016 |
| Country | Israel | United States |
| Employees | N/A | 28 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1M | 15.7M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | CMMB | BNZI |
|---|---|---|
| Price | $2.06 | $1.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $25.00 | $23.00 |
| AVG Volume (30 Days) | 71.3K | ★ 585.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 101.67 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $185.61 |
| Revenue Next Year | N/A | $32.86 |
| P/E Ratio | $52.01 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.87 | $0.54 |
| 52 Week High | $3.86 | $4.44 |
Technical Indicators
Market Signals| Indicator | CMMB | BNZI |
|---|---|---|
| Relative Strength Index (RSI) | 60.58 | 39.25 |
| Support Level | $1.48 | $0.92 |
| Resistance Level | $2.24 | $1.04 |
| Average True Range (ATR) | 0.21 | 0.06 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 79.92 | 4.73 |
Price Performance
Historical ComparisonAbout CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.